3 results  1 of 1 

1 Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer
Emre Günakan, Yusuf Aytaç Tohma, Latife Atasoy Karakaş, Hüseyin Akıllı, Asuman Nihan Haberal, Ali Ayhan
Obstet Gynecol Sci.2020;63(4):464-469.   Published online 2020 June 19     DOI: http://dx.doi.org/10.5468/ogs.19204
      
2 Disappearance of Serum Methylated p16 Indicates Longer Survival in Patients with Gastric Cancer
Han-Ki Lim, Joong-Min Park, Kyong-Choun Chi, Eun-Ju Lee, Eun-Mi Jeong
J Gastric Cancer.2013;13(3):157-163.   Published online 2013 September 30     DOI: http://dx.doi.org/10.5230/jgc.2013.13.3.157
      
3 Promoter Methylation of CDKN2A, RARβ, and RASSF1A in Non-Small Cell Lung Carcinoma: Quantitative Evaluation Using Pyrosequencing
Jung Uee Lee, Hae Joung Sul, Ji Woong Son
Tuberc Respir Dis.2012;73(1):11-21.   Published online 2012 July 31     DOI: http://dx.doi.org/10.4046/trd.2012.73.1.11
      

 1 of 1